Amlodipine Besylate Granules(Bio-Sincerity Pharma)

苯磺酸氨氯地平颗粒(百诚医药)

Report date: 2025/03/07 16:08:27

Base Information

Drug NameAmlodipine Besylate Granules(Bio-Sincerity Pharma)
Drug Alias Nameamlodipine苯磺酸氨氯地平颗粒(2.2类改良型)amlodipinoamlodipinumAmlodipine Besilate +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionCoronary Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypertensionCoronary Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A